Wendy Max, Ph.D. is Professor of Health Economics and Co-Director of the Institute for Health & Aging at the University of California, San Francisco. She has been on the faculty at UCSF since 1987. Dr. Max holds a PhD in economics from the University of Colorado, Boulder. Her recent research has focused on modeling the economic impact of tobacco on healthcare expenditures. She has estimated national costs of smoking; costs to Medicare, Medicaid, and private payers; costs in California; and the impact on communities of color. She is currently developing models of the impact of secondhand exposure on healthcare expenditures in California and the US. Her other current projects include evaluating an integrated primary healthcare program in rural Malawi and looking at the economic impact of hurricane Katrina on the primary healthcare safety net in New Orleans. Dr. Max has also conducted studies related to the economic impact of Alzheimer’s disease, cancer, and injuries.
Honors and Awards
Hal Luft Mentoring Award in Health Services and Health Policy Research, UCSF, 2012
Helen Nahm Research Award, UCSF, 2010
Honorary Visiting Professorship, Beijing Normal University, Beijing,, 2001-2006
Real-world effectiveness of smoking cessation strategies for young and older adults: Findings from a nationally representative cohort.
Medical and socio-demographic characteristics associated with patient-perceived continuity of primary care: A cross-sectional survey in Hangzhou, China.
Nurse Practitioners and Physician Assistants: An Underestimated Workforce for Older Adults with Cancer.
Effects of cigarette prices on intention to quit, quit attempts, and successful cessation among African American smokers.
Infrequent and Frequent Nondaily Smokers and Daily Smokers: Their Characteristics and Other Tobacco Use Patterns.
Relationship between spending on electronic cigarettes, 30-day use, and disease symptoms among current adult cigarette smokers in the U.S.
The Association of Menthol Cigarette Use With Quit Attempts, Successful Cessation, and Intention to Quit Across Racial/Ethnic Groups in the United States.
Factors associated with short-term transitions of non-daily smokers: socio-demographic characteristics and other tobacco product use.
Sociodemographic Differences Among U.S. Children and Adults Exposed to Secondhand Smoke at Home: National Health Interview Surveys 2000 and 2010.
Comparing the cost-effectiveness of four novel risk markers for screening asymptomatic individuals to prevent cardiovascular disease (CVD) in the US population.
Study protocol for a cluster randomized trial of the Community of Voices choir intervention to promote the health and well-being of diverse older adults.
Home exposure to secondhand smoke among people living in multiunit housing and single family housing: a study of California adults, 2003-2012.
Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease.
An evaluation of the FDA's analysis of the costs and benefits of the graphic warning label regulation.
Predictive value of updating Framingham risk scores with novel risk markers in the U.S. general population.
Attention deficit hyperactivity disorder among children exposed to secondhand smoke: a logistic regression analysis of secondary data.
Validity study of the K6 scale as a measure of moderate mental distress based on mental health treatment need and utilization.
The impact of changes in tobacco control funding on healthcare expenditures in California, 2012-2016.
Six climate change-related events in the United States accounted for about $14 billion in lost lives and health costs.
Cigarette smoking and serious psychological distress: a population-based study of California adults.
Evaluation of the economic impact of California's Tobacco Control Program: a dynamic model approach.
Who is exposed to secondhand smoke? Self-reported and serum cotinine measured exposure in the U.S., 1999-2006.
Women's Initiative for Nonsmoking-VII: evaluation of health service utilization and costs among women smokers with cardiovascular disease.
Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective.
The economic costs of cardiovascular disease mortality in California, 1991: implications for public health policy.
Tobacco Smoke Pollution
Health Care Costs
Policy-making Institute Or Agency
Brief Implementation Science Training Courses
Interdisciplinary Research Collaboration
International (public Health)
Implementation & Dissemination Science Listservs
Work Primarily With Secondary Data
Tobacco-related Diseases (cancer
Socioeconomically Marginalized Groups